Literature DB >> 6274970

In vitro susceptibility of antimony-resistant Leishmania to alternative drugs.

J D Berman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6274970     DOI: 10.1093/infdis/145.2.279

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo.

Authors:  W Raether; H Seidenath
Journal:  Z Parasitenkd       Date:  1984

2.  Activity of purine analogs against Leishmania tropica within human macrophages in vitro.

Authors:  J D Berman; L S Lee; R K Robins; G R Revankar
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

3.  In vitro and in vivo activities of formycin B against Trypanosoma cruzi.

Authors:  R E McCabe; J S Remington; F G Araujo
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

4.  Metabolism of formycin B by Leishmania amastigotes in vitro. Comparative metabolism in infected and uninfected human macrophages.

Authors:  J D Berman; P Rainey; D V Santi
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

5.  Targeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylase.

Authors:  Laura-Isobel McCall; Amale El Aroussi; Jun Yong Choi; Debora F Vieira; Geraldine De Muylder; Jonathan B Johnston; Steven Chen; Danielle Kellar; Jair L Siqueira-Neto; William R Roush; Larissa M Podust; James H McKerrow
Journal:  PLoS Negl Trop Dis       Date:  2015-03-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.